Best Topics

Volker Gerdts: Latest News

All news where Volker Gerdts is mentioned

Volker Gerdts - VIDO-InterVac running vaccine trial in Africa as Omicron variant spreads - globalnews.ca
globalnews.ca
77%
298
VIDO-InterVac running vaccine trial in Africa as Omicron variant spreads
VIDO-InterVac director and CEO Dr. Volker Gerdts tells Global News Morning they are trialling their Saskatoon-made COVID-19 vaccine in Africa — and gives his thoughts on the Omicron variant.
Volker Gerdts covid-19 vaccine CEO
Volker Gerdts - Update on VIDO-InterVac vaccine progress, donation to facility - globalnews.ca
globalnews.ca
38%
813
Update on VIDO-InterVac vaccine progress, donation to facility
VIDO-InterVac director Volker Gerdts joins Global News Morning to talk about a $1 million donation to the facility, and updates their COVID-19 vaccine, including expanding their trials to Saskatoon.
Volker Gerdts covid-19 vaccine donates
Volker Gerdts - Hospitals of Regina Foundation invests $150K in VIDO-InterVac lab - globalnews.ca
globalnews.ca
78%
342
Hospitals of Regina Foundation invests $150K in VIDO-InterVac lab
The lab’s director, Dr. Volker Gerdts, welcomed the investment. He said it would help boost the work the lab is doing, like that of Alyon Kelvin, who recently identified the effects of “longhaul” COVID-19.
Volker Gerdts hospital covid-19
Volker Gerdts - Promising first phase for VIDO-InterVac vaccine development - globalnews.ca
globalnews.ca
83%
181
Promising first phase for VIDO-InterVac vaccine development
VIDO InterVac director and CEO Dr. Volker Gerdts tells Global News Morning the first phase of their locally-made COVID-19 vaccine was very promising, and they’re looking for local volunteers this summer.
Volker Gerdts covid-19 vaccine Volunteers
Volker Gerdts - The latest from VIDO-InterVac on new funding - globalnews.ca
globalnews.ca
75%
192
The latest from VIDO-InterVac on new funding
VIDO InterVac Director and CEO Volker Gerdts joins Global News Morning to discuss new funding from Blue Cross Saskatchewan along with an update on COVID-19 research at the Canadian Light Source.
Volker Gerdts covid-19
Volker Gerdts - Shaping Saskatchewan: Dr. Volker Gerdts focused on developing COVID-19 vaccine - globalnews.ca
globalnews.ca
95%
951
Shaping Saskatchewan: Dr. Volker Gerdts focused on developing COVID-19 vaccine
Dr. Volker Gerdts has been working on a home-grown solution to the COVID-19 pandemic and is proud of what he and his team at VIDO have accomplished so far.
Volker Gerdts covid-19 pandemic vaccine
Volker Gerdts - VIDO, Global Nexus teaming up to fight COVID-19, future pandemics - globalnews.ca - Canada - county Hamilton
globalnews.ca
52%
792
VIDO, Global Nexus teaming up to fight COVID-19, future pandemics
McMaster University and the University of Saskatchewan are joining forces in the fight against COVID-19.Officials with both universities say they have signed a partnership agreement to accelerate vaccine and drug development, human and animal clinical trials and to create new diagnostic tools.
Volker Gerdts Canada county Hamilton covid-19 McMaster University Coronavirus
Volker Gerdts - Coronavirus: VIDO-InterVac director explains vaccine, variant research being conducted in Saskatchewan - globalnews.ca
globalnews.ca
68%
517
Coronavirus: VIDO-InterVac director explains vaccine, variant research being conducted in Saskatchewan
Dr. Volker Gerdts, director of the Vaccine and Infectious Disease Organization (VIDO) explained on Tuesday how VIDO is conducting research on COVID-19 variants and adjusting vaccines to the new variants.
Volker Gerdts covid-19 vaccine Coronavirus
Scott Moe - Volker Gerdts - Saskatchewan government commits $15M to pandemic research at VIDO - globalnews.ca - Canada
globalnews.ca
48%
325
Saskatchewan government commits $15M to pandemic research at VIDO
Scott Moe said the COVID-19 pandemic shows why Canada needs to be a leader in the research, development and production of vaccines.“The place that should happen is right here in Saskatchewan, at VIDO-InterVac in Saskatoon,” Moe said Tuesday in a statement.“VIDO has made world-first breakthroughs and achieved significant momentum in vaccine and disease research, most recently with COVID-19 vaccine development, and this new facility will strengthen their position as Canada’s Centre for Pandemic Research.” City of Saskatoon signals support for new $65M VIDO vaccine lab However, Moe said provincial funding is contingent on the federal government committing funds to the project.Moe said he has written a letter to the federal government
Scott Moe Volker Gerdts Canada covid-19 COVID-19 Vaccine Coronavirus
Volker Gerdts - VIDO COVID-19 vaccine moves to Phase 1 clinical testing - globalnews.ca - Canada - county Halifax
globalnews.ca
91%
751
VIDO COVID-19 vaccine moves to Phase 1 clinical testing
VIDO says it has taken another step forward in developing a made-in-Canada COVID-19 vaccine.The Saskatoon-based science and research facility said 108 volunteers have been selected to take part in its COVAC-2 vaccine trial.“We are excited to start clinical trials,” VIDO director Dr.
Volker Gerdts Canada county Halifax covid-19 COVID-19 Vaccine Coronavirus
Justin Trudeau - Volker Gerdts - VIDO-InterVac vaccine in clinical trials, production facility operational next year - globalnews.ca - Canada
globalnews.ca
47%
367
VIDO-InterVac vaccine in clinical trials, production facility operational next year
COVID-19 vaccines at home — and Saskatchewan is a key player.Prime Minister Justin Trudeau said the University of Saskatchewan’s Vaccine and Infectious Disease Organization, VIDO-InterVac, could pump out a huge portion of homegrown vaccines.“The good news we’ve just heard is that VIDO-InterVac now projects they will be able to produce up to 40 million doses annually,” Trudeau said at a new conference Tuesday morning.“We need as much domestic capacity for vaccine production as possible.” Saskatoon lab receives Health Canada authorization for COVID-19 vaccine clinical trial VIDO-InterVac director Dr.
Justin Trudeau Volker Gerdts Canada covid-19 Coronavirus
Volker Gerdts - Saskatoon lab receives Health Canada authorization for COVID-19 vaccine clinical trial - globalnews.ca - Canada
globalnews.ca
54%
734
Saskatoon lab receives Health Canada authorization for COVID-19 vaccine clinical trial
coronavirus vaccine.The Saskatoon-based lab at the University of Saskatchewan received the green light from Health Canada to start Phase 1 of its clinical vaccine trials.“The approval to initiate a human clinical trial is a milestone for VIDO,” Dr.
Volker Gerdts Canada covid-19 vaccine Coronavirus
Volker Gerdts - VIDO-InterVac update on COVID-19 antiviral funding, vaccine research - globalnews.ca
globalnews.ca
67%
940
VIDO-InterVac update on COVID-19 antiviral funding, vaccine research
VIDO-InterVac director Dr. Volker Gerdts joins Global News Morning for an update on their COVID-19 vaccine research, along with recent funding for antiviral research.
Volker Gerdts covid-19 vaccine
Volker Gerdts - When can Canadians expect a COVID-19 vaccine? - globalnews.ca
globalnews.ca
45%
601
When can Canadians expect a COVID-19 vaccine?
Dr. Volker Gerdts tells The Morning Show Canadians can expect a possible vaccination for COVID-19 next spring.
Volker Gerdts covid-19 vaccine
Volker Gerdts - VIDO-InterVac one step from COVID-19 vaccine clinical trials - globalnews.ca
globalnews.ca
85%
127
VIDO-InterVac one step from COVID-19 vaccine clinical trials
VIDO-Intervac is one step away from getting the green light for clinical trials of their COVID-19 vaccine. Director Dr. Volker Gerdts tells us what that step is, and when trials could begin.
Volker Gerdts covid-19 vaccine
Volker Gerdts - Saskatchewan - VIDO-InterVac shifts focus to hamsters in efforts to create COVID-19 vaccine - globalnews.ca
globalnews.ca
36%
144
VIDO-InterVac shifts focus to hamsters in efforts to create COVID-19 vaccine
novel coronavirus.After demonstrating the vaccine’s efficacy in ferrets, VIDO-InterVac is now focusing on comparing the results in hamsters.“This provides us more confidence in our results and allows us to start testing the safety of the vaccine and that is critical,” said Dr. Volker Gerdts, VIDO-InterVac CEO.
Volker Gerdts Saskatchewan covid-19 Saskatchewan Coronavirus Coronavirus
Volker Gerdts - Update on Vido-Intervac’s COVID-19 vaccine - globalnews.ca
globalnews.ca
52%
695
Update on Vido-Intervac’s COVID-19 vaccine
VIDO-InterVac director and CEO Dr. Volker Gerdts joins Global Morning News to share the next steps in the process following a major milestone in their development of a potential COVID-19 vaccine.
Volker Gerdts covid-19 vaccine
Volker Gerdts - Canada’s USask reports positive preclinical data for Covid-19 vaccine - pharmaceutical-technology.com - Canada
pharmaceutical-technology.com
89%
100
Canada’s USask reports positive preclinical data for Covid-19 vaccine
The University of Saskatchewan (USask) in Canada has reported positive data from preclinical studies of the Covid-19 vaccine candidate developed by its Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac).
Volker Gerdts Canada covid-19 vaccine Government
Volker Gerdts - Coronavirus: USask researchers expect human clinical trials for vaccine in the fall - globalnews.ca - China
globalnews.ca
88%
156
Coronavirus: USask researchers expect human clinical trials for vaccine in the fall
University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) team has seen promising results in their clinical trials for a COVID-19 vaccine.
Volker Gerdts China covid-19 coronavirus news vaccine Coronavirus
Volker Gerdts - Update on VIDO-InterVac ferret testing - globalnews.ca
globalnews.ca
60%
571
Update on VIDO-InterVac ferret testing
VIDO-InterVac has made progress with the testing of their coronavirus vaccine on ferrets. Dr. Volker Gerdts joins us to discuss the what the early results are dictating and when we should expect a potential vaccine.
Volker Gerdts testing vaccine Coronavirus
Volker Gerdts - Coronavirus: Saskatoon lab tests potential vaccine on ferrets - globalnews.ca
globalnews.ca
66%
372
Coronavirus: Saskatoon lab tests potential vaccine on ferrets
A University of Saskatchewan lab says it is on the forefront of developing a vaccine for the novel coronavirus and a manufacturing lab to produce it.
Volker Gerdts covid-19 coronavirus news coronavirus update Coronavirus
Volker Gerdts - VIDO-InterVac receives $23.3M from feds in fight against COVID-19 - globalnews.ca
globalnews.ca
94%
450
VIDO-InterVac receives $23.3M from feds in fight against COVID-19
The Vaccine and Infectious Disease Organization – International Vaccine Centre (VIDO-InterVac) is receiving $23.3 million in federal funding in the fight against COVID-19.
Volker Gerdts covid-19 coronavirus news vaccine
COVID-19
United States
United States
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
India
India
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
Brazil
Brazil
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
United Kingdom
United Kingdom
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
Russia
Russia
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
Detail statistic
SNP MP calls for ban on tanning salons to help reduce risk of skin cancer caused by sunbeds
New PIP claims worth up to £184 each week for people with these long-term health issues
Teen Charlie Millers died on short-staffed mental health ward, inquest told
Richest 'The Big Bang Theory' Cast Members Ranked From Lowest to Highest (& the Wealthiest Has a Net Worth of $160 Million!)
Designer Rebecca Minkoff Joins Season 15 Cast of 'Real Housewives of New York City' (Report)
How to entertain yourself when you stuck inside due to a pandemic
About Us

Covid-19.rehab - the latest news concerning the spread of the SARS-CoV-2 coronavirus (formerly 2019-nCoV), as well as the infectious disease that it causes COVID-19, in separate countries and in the world as a whole. Current news on the topic of coronavirus SARS-CoV-2. Quarantine, pandemic 2020, epidemic: what is it, when will it come to end, precautions and how to protect yourself from this disease. The most honest news, no fakes! To keep up with the latest news, stay tuned for updates on the site! Every day we will collect news and statistics on coronavirus from around the world for you to be aware of this topic.

Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic

Categories
Info
For advertisers
Add Post

©2024. All rights reserved.

DMCA